Cite
HARVARD Citation
Tsitoura, D. et al. (n.d.). Early clinical evaluation of the intranasal TLR7 agonist GSK2245035: Use of translational biomarkers to guide dosing and confirm target engagement. Clinical pharmacology & therapeutics. 98 (4), pp. 369-380. [Online].